{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:51:19Z","timestamp":1781880679331,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spinal muscular atrophy (SMA) issues from mutations in the <jats:italic>survival of motor neuron (SMN) 1<\/jats:italic> gene. Loss or reduction of the SMN protein results in progressive muscle weakness. Whether this protein deficiency also affects cortical function remains unclear. While no data on adult patients exists so far, prior studies in children with SMA indicate cognitive abilities equal or even superior to healthy controls. This may suggest a possible compensatory\u2014neuropsychological and interactional\u2014process. The goal of this study was to assess the cognitive profile of adult patients with SMA, with a special focus on social cognition as a potential candidate for enhanced cognitive function through compensatory processes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a cross-sectional design, N\u2009=\u200931 adult SMA patients (types II and III) were assessed for language, verbal fluency, memory, visuospatial abilities and executive function with the Edinburgh Cognitive and Behavioural ALS Screen and for social cognition with the Reading the Mind in the Eyes Test. Physical function was evaluated using the Hammersmith Functional Motor Scale Expanded. N\u2009=\u200919 neurologically healthy controls were matched with patients for age, sex and years of education.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In none of the abovementioned cognitive domains significant differences between SMA patients and controls were found. Among patients, no differences between type II SMA and type III SMA were detected for any domain. However, a trend towards better social cognition in patients with type II SMA, compared to those with type III SMA was observed. Furthermore, a significant inverse correlation of physical function and executive function was detected: lower motor function was associated with a better executive function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study shows cognitive abilities in adult SMA in the normal range for all assessed domains. Thus, reduction of SMN protein has no obvious negative impact on cognitive function. Executive functions are identified as the only cognitive domain correlated with disease severity. Therefore, executive functions may play a role in the adaptation to physical restrictions in SMA, making them a promising target for future research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01661-9","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T19:04:06Z","timestamp":1609959846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA)"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5707-7840","authenticated-orcid":false,"given":"Lucas","family":"Mix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Schreiber-Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Wurster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Uzelac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Platen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gipperich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gresa","family":"Ranxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wieselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Osmanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Lul\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"7","key":"1661_CR1","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","volume":"264","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Leary R, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264(7):1465\u201373. https:\/\/doi.org\/10.1007\/s00415-017-8549-1.","journal-title":"J Neurol"},{"issue":"1","key":"1661_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy\u2014a literature review. Orphanet J Rare Dis. 2017;12(1):124. https:\/\/doi.org\/10.1186\/s13023-017-0671-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1661_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346. https:\/\/doi.org\/10.1016\/j.ncl.2015.07.004.","journal-title":"Neurol Clin"},{"issue":"1","key":"1661_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0022-510x(96)00284-5","volume":"146","author":"K Zerres","year":"1997","unstructured":"Zerres K, Rudnik-Sch\u00f6neborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa-Petrusewicz I. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;146(1):67\u201372. https:\/\/doi.org\/10.1016\/s0022-510x(96)00284-5.","journal-title":"J Neurol Sci"},{"key":"1661_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/TCRM.S172291","volume":"15","author":"T Dangouloff","year":"2019","unstructured":"Dangouloff T, Servais L. Clinical evidence supporting early treatment of patients with spinal muscular atrophy: current perspectives. Ther Clin Risk Manag. 2019;15:1153\u201361. https:\/\/doi.org\/10.2147\/TCRM.S172291.","journal-title":"Ther Clin Risk Manag"},{"issue":"1\u20132","key":"1661_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1162\/1064546053278973","volume":"11","author":"L Smith","year":"2005","unstructured":"Smith L, Gasser M. The development of embodied cognition: six lessons from babies. Artif Life. 2005;11(1\u20132):13\u201329. https:\/\/doi.org\/10.1162\/1064546053278973.","journal-title":"Artif Life"},{"issue":"8","key":"1661_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2012.04.004","volume":"35","author":"A Waite","year":"2012","unstructured":"Waite A, Brown SC, Blake DJ. The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci. 2012;35(8):487\u201396. https:\/\/doi.org\/10.1016\/j.tins.2012.04.004.","journal-title":"Trends Neurosci"},{"issue":"Pt 18","key":"1661_CR8","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1242\/jcs.093831","volume":"127","author":"H Meyer","year":"2014","unstructured":"Meyer H, Weihl CC. The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127(Pt 18):3877\u201383. https:\/\/doi.org\/10.1242\/jcs.093831.","journal-title":"J Cell Sci"},{"issue":"5","key":"1661_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cne.21010","volume":"497","author":"M Briese","year":"2006","unstructured":"Briese M, Richter DU, Sattelle DB, Ulfig N. SMN, the product of the spinal muscular atrophy-determining gene, is expressed widely but selectively in the developing human forebrain. J Comp Neurol. 2006;497(5):808\u201316. https:\/\/doi.org\/10.1002\/cne.21010.","journal-title":"J Comp Neurol"},{"issue":"8","key":"1661_CR10","first-page":"223","volume":"23","author":"V Dubowitz","year":"1967","unstructured":"Dubowitz V. Infantile muscular atrophy\u2014a broad spectrum. Clin Proc Child Hosp Dist Columbia. 1967;23(8):223\u201339.","journal-title":"Clin Proc Child Hosp Dist Columbia"},{"issue":"2","key":"1661_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1469-8749.1987.tb02138.x","volume":"29","author":"TB Whelan","year":"1987","unstructured":"Whelan TB. Neuropsychological performance of children with Duchenne muscular dystrophy and spinal muscle atrophy. Dev Med Child Neurol. 1987;29(2):212\u201320. https:\/\/doi.org\/10.1111\/j.1469-8749.1987.tb02138.x.","journal-title":"Dev Med Child Neurol"},{"issue":"5\u20136","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/s0960-8966(06)80008-8","volume":"2","author":"C Billard","year":"1992","unstructured":"Billard C, Gillet P, Signoret JL, et al. Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy. Neuromuscul Disord. 1992;2(5\u20136):371\u20138. https:\/\/doi.org\/10.1016\/s0960-8966(06)80008-8.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"1661_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1469-8749.1998.tb15351.x","volume":"40","author":"C Billard","year":"1998","unstructured":"Billard C, Gillet P, Barthez M, Hommet C, Bertrand P. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol. 1998;40(1):12\u201320. https:\/\/doi.org\/10.1111\/j.1469-8749.1998.tb15351.x.","journal-title":"Dev Med Child Neurol"},{"key":"1661_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fpsyg.2014.00521","volume":"5","author":"O Oudgenoeg-Paz","year":"2014","unstructured":"Oudgenoeg-Paz O, Rivi\u00e8re J. Self-locomotion and spatial language and spatial cognition: insights from typical and atypical development. Front Psychol. 2014;5:521. https:\/\/doi.org\/10.3389\/fpsyg.2014.00521.","journal-title":"Front Psychol"},{"issue":"2","key":"1661_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejpn.2005.02.001","volume":"9","author":"C B\u00e9nony","year":"2005","unstructured":"B\u00e9nony C, B\u00e9nony H. Precocity of the acquisition of language and type II spinal muscular atrophy in 3\u20134-year-old children: a study of 12 cases. Eur J Paediatr Neurol. 2005;9(2):71\u20136. https:\/\/doi.org\/10.1016\/j.ejpn.2005.02.001.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1661_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1207\/S15326942DN2103_4","volume":"21","author":"J Rivi\u00e8re","year":"2002","unstructured":"Rivi\u00e8re J, L\u00e9cuyer R. Spatial cognition in young children with spinal muscular atrophy. Dev Neuropsychol. 2002;21(3):273\u201383. https:\/\/doi.org\/10.1207\/S15326942DN2103_4.","journal-title":"Dev Neuropsychol"},{"issue":"3","key":"1661_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0885-2014(03)00003-0","volume":"18","author":"J Riviere","year":"2003","unstructured":"Riviere J, Lecuyer R. The C-not-B error: a comparative study. Cognitive Dev. 2003;18(3):285\u201397. https:\/\/doi.org\/10.1016\/S0885-2014(03)00003-0.","journal-title":"Cognitive Dev"},{"issue":"2","key":"1661_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s0960-8966(01)00274-7","volume":"12","author":"A von Gontard","year":"2002","unstructured":"von Gontard A, Zerres K, Backes M, et al. Intelligence and cognitive function in children and adolescents with spinal muscular atrophy. Neuromuscul Disord. 2002;12(2):130\u20136. https:\/\/doi.org\/10.1016\/s0960-8966(01)00274-7.","journal-title":"Neuromuscul Disord"},{"key":"1661_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0024-3841(01)00054-7","volume":"112","author":"JS Sieratzki","year":"2002","unstructured":"Sieratzki JS, Woll B. Toddling into language: precocious language development in motor-impaired children with spinal muscular atrophy. Lingua. 2002;112:423\u201333. https:\/\/doi.org\/10.1016\/S0024-3841(01)00054-7.","journal-title":"Lingua"},{"issue":"1\u20132","key":"1661_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/21678421.2013.805784","volume":"15","author":"S Abrahams","year":"2014","unstructured":"Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1\u20132):9\u201314. https:\/\/doi.org\/10.3109\/21678421.2013.805784.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"1661_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1469-7610.1997.tb01599.x","volume":"38","author":"S Baron-Cohen","year":"1997","unstructured":"Baron-Cohen S, Jolliffe T, Mortimore C, Robertson M. Another advanced test of theory of mind: evidence from very high functioning adults with autism or asperger syndrome. J Child Psychol Psych. 1997;38(7):813\u201322. https:\/\/doi.org\/10.1111\/j.1469-7610.1997.tb01599.x.","journal-title":"J Child Psychol Psych"},{"key":"1661_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnagi.2018.00011","volume":"10","author":"ML Schroeter","year":"2018","unstructured":"Schroeter ML, Pawelke S, Bisenius S, et al. A modified reading the mind in the eyes test predicts behavioral variant frontotemporal dementia better than executive function tests. Front Aging Neurosci. 2018;10:11. https:\/\/doi.org\/10.3389\/fnagi.2018.00011.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1661_CR23","doi-asserted-by":"publisher","first-page":"e0172346","DOI":"10.1371\/journal.pone.0172346","volume":"12","author":"D Ramsey","year":"2017","unstructured":"Ramsey D, Scoto M, Mayhew A, et al. Revised Hammersmith Scale for spinal muscular atrophy: a SMA specific clinical outcome assessment tool. PLoS ONE. 2017;12(2):e0172346. https:\/\/doi.org\/10.1371\/journal.pone.0172346.","journal-title":"PLoS ONE"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01661-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01661-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01661-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:17:39Z","timestamp":1609964259000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01661-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01661-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committees of Ulm University (approval number 19\/12) and MHH (approval number 6269). Written informed consent was obtained from all participants in advance to study enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study participants gave their written consent to the publication of anonymous (cohort) data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: LM reports no conflict of interests. OSK has received honoraria as a speaker\/consultant and\/or funding for travel expenses from the German Neuromuscular Society [Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.)], Novartis, Biogen GmbH, the Jain Foundation and Biermann Verlag GmbH. She has received academic research support by the Ludwig-Maximilians-University of Munich, FoeFoLe program, Reg.-No. 747, 11\/11-05\/13, and the Hannover Medical School Young Faculty Program, 2018-2020. She has received research support from the Friedrich-Baur-GmbH, Burgkunstadt 12\/13-12\/15 and the German Neuromuscular Society \u201cDeutsche Gesellschaft fuer Muskelkranke (DGM e.V.), 2019-2021. CDW received honoraria from Biogen (as an Advisory board member and for lectures) and from Hoffmann-La Roche (as a consultant and Advisory board member). She also received travel expenses from Biogen. ZU received honoraria from Biogen for lectures and consultation. SP reports no conflict of interests. CG reports no conflict of interests. GR received travel funding from Biogen GmbH. GW reports no conflicts of interest. AO has received honoraria as a speaker\/consultant from the German Neuromuscular Society \u201cDeutsche Gesellschaft fuer Muskelkranke (DGM e.V.)\u201d and Biogen GmbH. She has received academic research support by PRACTIS\u2014Clinician Scientist Program of Hannover Medical School, funded by the German Research Foundation (DFG, ME 3696\/3-1). ACL received honoraria from AB Science, Biogen, Cytokinetics, GSK, Orion Pharma, Novartis, Tau Rx Therapeutics Ltd., TEVA Pharmaceuticals, Mitsubishi and Hoffmann-La Roche. SPe has received grants by the German Neuromuscular Society [Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.)], the Federal Ministry of Education and Research (BMBF), the German Israeli Foundation (GIF) for Scientific Research and Development and the EU Joint Programme for Neurodegenerative Disease Research (JPND). She has received speaking honoraria from Desitin Pharma, Biogen GmbH, Novartis and TEVA as well as fees for consulting from Biogen GmbH, Roche Pharma, Cytokinetics Inc., DL reports no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}